The 2023 agenda will include courses on the impact of COVID-19, dementia, epilepsy, hearing loss, migraine, multiple sclerosis, and stroke, as well as special interest sessions on rare CNS disorders such as amyotrophic lateral sclerosis (ALS), and Rett syndrome